Snibe announced a global strategic cooperation with Thermo Fisher Scientific
Release Date:2019-08-31
From August 29thto 31st, 2019,
the 15thNational Congress of Laboratory Medicine (NCLM 2019),
hosted by Chinese Medical Association and Chinese Society of Laboratory
Medicine, was held at Suzhou International Expo Centre.
The Total laboratory automation solution SATLARS-TCA,
a brand new product jointly developed by Thermo Fisher Scientific and Snibe,
was launched officially and became the focus of the congress.
Product Launch of SATLARS-TCA
Participants include Prof. Wang Chengbin,Head of Chinese Society of
Laboratory Medicine and director of Chinese PLA General Hospital Medical
Laboratory; Prof. Cong Yulong, Head of Chinese Geriatrics Society and former president
of Chinese Society of Laboratory Medicine; Prof. Sunil Sethi, Presient of APFCB,
Executive Board member of the International Federation of Clinical Chemistry
and Laboratory Medicine (IFCC), and Dr. Helen Martin, secretary of APFCB and
former president of AACB (Australasian Association of Clinical Biochemists).
Product of the joint efforts of the two giants
As the first CLIA manufacturer who gets FDA cleared
in China, Snibe has been focusing on In Vitro diagnostic area since its
establishment. To date, Snibe has built business relations with more than 140
countries and regions and has more than 11,000 units of installation all over
the world.
Thermo Fisher Scientific, with annual revenue
exceeding $24 billion and a global team of more than 70,000
employees, is the world leader in serving science and the Giant in laboratory
equipment manufacturing,
The Joint development and launch of SATLARS-TCA by a leading
CLIA company in China and the world leader in laboratory equipment
manufacturing marks Snibe’s entering the intelligent laboratory race.
Mutual
development under strategic cooperation
At the SATLARS-TCA signing ceremony, Mr. Zhang
Xiaohong, Vice President of Snibe and Mr. Roberto Mendes, President of Thermo
Fisher Scientific Automation Product Line signed the global strategic
cooperation agreement.
The Signing Ceremony
Guests and Representatives from Both Sides
Witnessing
the launch
At the beginning of the ceremony, Mr. Zhang Xiaohong
delivered a welcome speech to the attendees, followed by the excellent speeches
respectively by Prof. Wang Chengbin, Prof. Cong Yulong, Prof. Sunil Sethi and
Mr. Roberto Mendes.
As the guests pressing the launch button, SATLARS-TCA
was unveiled and came in the spotlight.
The advantages of the SATLARS-TCA solution can be
listed as follow:
① Greatly reduce the laboratory operating costs.
② High test efficiency with the combination of Snibe
fully-automated CLIA system MAGLUMI?X8 (600Test/Hour) and
Biochemistry analyzer (will be launched soon).
③ Lower space requirement and higher space utilization
Combining all these advantages, SATLARS-TCA matches
the development goals of modern medical laboratories in terms of automation, informatization
and intelligence, featuring with super flexibility, high throughput and scalability.
This system provides a customized solution for global medical laboratories and brings
better service to patients all over the world.